What is it? Why is it important?

Quality Control (QC) is an essential part of Quality Assurance, using a systematic review of implemented study procedures and processes to ensure that

 

Non-compliance results in findings that must be addressed and resolved. In this regard, the SP-INV is responsible to implement a risk-based QMS. A risk-based QMS aims at managing study risks to ensure the safety and quality of the study.

More

Example of QC measures

Monitoring plays a key role in helping the SP-INV to evaluate compliance and perform QC checks at participating study sites.

 

Quality indicators include to:

  • Ensure patient eligibility criteria are consistently respected and followed as defined in the study protocol
  • Ensure traceability by properly documenting Informed Consent (IC) and comply with the IC process
  • Adhere to safety reporting timelines
  • Ensure adherence to scheduled study visits and procedures (e.g. blood draw, questionnaire, timing), including their documentation
  • Complete data entry within required timelines
  • Document study visit in the CRF, and ensure updates are entered in medical records
  • Document and track staff trainings (e.g. ICH GCP certificate, IC process, IMP/IMD handling)
  • Correct handling of the investigational product (e.g. IMP/IMD access and temperature control, inventory log with traceability on dispense, return, destruction)

What do I need to do?

As a SP-INV define the QC strategy for your study. Base QC control activities according to identified study risks, such as:

 

Monitoring is an important QC activity used to monitor study conduct. To ensure compliance with QC activities its strategy should be documented in a monitoring plan.

 

For more information refer to Monitoring in this Study Guide

More

Based on the QC strategy of your study provide applicable:

  • Written SOPs and WIs: These documents give detailed guidance on how standards, processes, and given requirements should be implemented in study core activities - in everyday work
  • Guidance on the handling of study risks, by documenting the risk management of your study in a RAF (e.g. including quality document)
  • Ensure to train staff on the QC activities of your study

Where can I get help?

Your local Research Support Centre can assist you with experienced staff regarding this topic

  • Basel, Departement Klinische Forschung (DKF), dkf.unibas.ch

  • Lugano, Clinical Trials Unit (CTU-EOC), ctueoc.ch

  • Bern, Department of Clinical Research (DCR), dcr.unibe.ch

  • Geneva, Clinical Research Center (CRC), crc.hug.ch

  • Lausanne, Clinical Research Center (CRC), chuv.ch

  • St. Gallen, Clinical Trials Unit (CTU), h-och.ch

  • Zürich, Clinical Trials Center (CTC), usz.ch

References

ICH GCP E6(R2) – see in particular guidelines

  • 1.47 QC definition
  • 5.1 Quality assurance and quality control
  • 5.18 Study monitoring

ISO 9001:2015 (access liable to costs) – see in particular section

  • Quality Management Systems

Documents

Abbreviations
  • CRF – Case Report Form
  • CTU – Clinical Trials Unit
  • eCRF – electronic Case Report Form
  • IC – Informed Consent
  • ICH GCP – International Council for Harmonisation Good Clinical Practice
  • ISO – International Organization for Standardization
  • IMP/IMD – Investigational Medicinal Product / Investigational Medicinal Device
  • QA – Quality Assurance
  • QC – Quality Control
  • QMS – Quality Management System
  • RAF – Risk Assessment Form
  • SD – Source Data
  • SOP – Standard Operating Procedures
  • SP-INV – Sponsor-Investigator
  • WI – Working Instruction
Development ↦ Quality and Risk ↦ Quality Control ↦ Aim
Study
Basic

Provides some background knowledge and basic definitions

Basic Monitoring
Concept

Starts with a study idea

Ends after having assessed and evaluated study feasibility

Concept Statistic Methodology
Concept Drug or Device
Development

Starts with confidence that the study is feasible

Ends after having received ethics and regulatory approval

Development Drug or Device
Set-Up

Starts with ethics and regulatory approval

Ends after successful study initiation

Set-Up Ethics and Laws
Set-Up Statistic Methodology
Set-Up Quality and Risk
Set-Up Drug or Device
Conduct

Starts with participant recruitment

Ends after the last participant has completed the last study visit

Conduct Statistic Methodology
Conduct Drug or Device
Completion

Starts with last study visit completed

Ends after study publication and archiving

Completion Drug or Device
Current Path (click to copy): Development ↦ Quality and Risk ↦ Quality Control ↦ Aim

Please note: the Easy-GCS tool is currently under construction.